Efficacy of Endolysin LysAB1245 Combined with Colistin as Adjunctive Therapy Against Colistin-Resistant Gram-Negative Bacteria
<b>Background:</b> Colistin resistance among Gram-negative nosocomial pathogens is an increasing concern. The bacteriophage-encoded lytic enzyme endolysin LysAB1245, which targets bacterial peptidoglycan, was evaluated as a potential antibacterial agent in combination with colistin as a therapeutic...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-05-01
|
| Schriftenreihe: | Antibiotics |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2079-6382/14/6/538 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
